-
Monkeypox A Nationally Notifiable Condition, CDC Poised To Announce: Report
Thursday, July 28, 2022 - 8:06am | 351Read More...Reuters reported that the U.S. Centers for Disease Control and Prevention (CDC) plans to make monkeypox infection a nationally notifiable condition. The disease has been declared a global health emergency by the World Health Organization. Related: Monkeypox Emergency Could Last...
-
Monkeypox Emergency Could Last Months, According To Experts
Wednesday, July 27, 2022 - 7:16am | 254Read More...Reuters reported that World Health Organization's (WHO) scientist advisors on monkeypox say the window is closing to stop its spread. The cases are currently doubling every two weeks, raising concerns that the outbreak will take several months to peak. "The alarm bell was going...
-
Bavarian Nordic's Monkeypox Vaccine Scores EU Approval As WHO Declares Global Health Emergency
Monday, July 25, 2022 - 9:20am | 368Read More...As the WHO declared the monkeypox outbreak a global health emergency, Bavarian Nordic A/S (OTC: BVNRY) obtained an expanded European label for its smallpox vaccine Imvanex, to include the surging monkeypox virus. On Saturday, WHO officially declared the outbreak a global...
-
6 Stocks To Watch As The World Health Organization Declares Monkeypox Outbreak A Global Emergency
Sunday, July 24, 2022 - 3:23pm | 635Read More...The World Health Organization (WHO) on Saturday declared the monkeypox outbreak a global emergency, its highest level of alert. WHO Director-General Tedros Adhanom Ghebreyesus said more than 16,000 cases in more than 75 countries have now been reported around the world....
-
Bavarian Nordic's Monkeypox Vaccine Gets Thumbs Up From EU Regulator
Friday, July 22, 2022 - 7:31am | 479Read More...The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a "positive opinion" recommending Bavarian Nordic A/S's (OTC: BVNRY) smallpox vaccine, Imvanex, be authorized to include protection against monkeypox on its label....
-
The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine
Monday, July 18, 2022 - 9:19am | 1274Read More...Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Sesen Bio To Pause Clinical Development Of Its Lead Bladder Cancer Candidate In the U.S. Based on a thorough reassessment, Sesen Bio Inc (NASDAQ: SESN) has decided to voluntarily...
-
Bavarian Nordic Inks Multiple Supply Pact For Its Monkey pox Vaccine, Updates FY22 Guidance
Monday, July 18, 2022 - 7:43am | 360Read More...Bavarian Nordic A/S (OTC: BVNRY) has signed several supply contracts with undisclosed countries for its liquid-frozen Jynneos, a non-replicating smallpox vaccine, the only FDA-approved vaccine against monkeypox. The contracts aim to ensure sufficient supply to meet the requirements...
-
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls For Developing Assays
Thursday, July 14, 2022 - 11:04am | 336Read More...Twist Bioscience Corp (NASDAQ: TWST) launched two human monkeypox virus synthetic DNA controls. Positive controls provide quality control measures for developing, verifying, and validating both next-generation sequencing (NGS) and polymerase chain reaction (PCR) assays. The...
-
White House Outlines New Monkeypox Vaccine Strategy: What You Need To Know
Wednesday, June 29, 2022 - 7:11am | 349Read More...The White House unveiled the first phase of its national monkeypox vaccine strategy, with plans to send doses to areas with confirmed outbreaks. The U.S. Department of Health and Human Services plans to distribute 296,000 doses of the Bavarian Nordic A/S's (OTC: BVNRY...
-
SIGA Technologies Announces $13M Worth Order For Its Monkeypox Treatment
Thursday, June 23, 2022 - 11:28am | 334Read More...SIGA Technologies Inc (NASDAQ: SIGA) has announced approximately $13 million in procurement orders for oral TPOXX (tecovirimat) The order includes $11 million for initial procaurement from two new international jurisdictions and an approximate $2 million order from a country in the...
-
US Expands Monkeypox Testing Capacity To Five Commercial Lab Companies
Thursday, June 23, 2022 - 7:20am | 343Read More...The Department of Health and Human Services (HHS), through the Centers for Disease Control and Prevention (CDC), started shipping monkeypox tests to five commercial laboratory companies to increase monkeypox testing capacity and access. The companies include Aegis Science, Laboratory...
-
EU, Bavarian Nordic Ink Supply Pact For 110,000 Monkeypox Vaccines
Tuesday, June 14, 2022 - 7:11am | 294Read More...European Health Emergency Preparedness and Response Authority (HERA) has ordered 110,000 doses of Bavarian Nordic A/S's (OTC: BVNRY) MVA-BN smallpox/monkeypox vaccine. Deliveries of vaccines to HERA will commence immediately and be completed during the following months. The...
-
Amid Monkeypox Outbreak, This 3X Leveraged ETF Provides Exposure To Health Sector: What To Watch
Monday, May 23, 2022 - 12:31pm | 555Read More...The Direxion Daily Healthcare Bull 3X Shares (NYSE: CURE) gapped up almost 2.52% higher on Monday in response to outbreaks of monkeypox being reported in several western nations. CURE is a triple leveraged fund that is designed to outperform 72 U.S. companies in the home health care sector. The...
-
Biden Says Monkeypox Could Be 'Consequential,' Something 'Everybody Should Be Concerned About'
Sunday, May 22, 2022 - 2:41pm | 396Read More...As a growing number of monkeypox cases are being reported in the U.S. and Europe, President Joe Biden on Sunday said that the outbreak should concern "everybody." What Happened: The president made the remarks to reporters in South Korea before boarding Air Force One en route to Japan. He...















